| Yoga Group (n = 27) | Control Group (n = 21) |  | |
---|---|---|---|---|
 |  | Mean (SD) | Mean (SD) | d a |
NIH Patient Reported Outcomes Measurement Information System Outcomes | Anxiety | |||
 Baseline | 54.0 (7.8) | 50.2 (8.6) | – | |
 Change from baseline, wk. 7 | −2.1 (5.0) | −0.7 (5.4) | − 0.27 | |
 Change from baseline, wk. 12 | −3.1 (5.7) | −1.3 (7.1) | −0.30 | |
 Change from baseline, wk. 16 | −4.2 (5.0) | −2.0 (7.2) | − 0.37 | |
Depression | ||||
 Baseline | 49.3 (7.9) | 45.2 (6.0) | – | |
 Change from baseline, wk. 7 | −3.7 (6.3) | 0.3 (5.4) | −0.64 | |
 Change from baseline, wk. 12 | −3.8 (5.4) | 1.6 (7.7) | − 0.78 | |
 Change from baseline, wk. 16 | −4.4 (7.0) | −0.6 (7.1) | −0.53 | |
Interest Sexual Activity | ||||
 Baseline | 43.0 (6.8) | 43.8 (8.0) | – | |
 Change from baseline, wk. 7 | −0.6 (5.8) | − 0.2 (4.6) | − 0.08 | |
 Change from baseline, wk. 12 | 0.4 (4.9) | 2.4 (4.2) | −0.43 | |
 Change from baseline, wk. 16 | 0.7 (5.0) | −0.4 (6.9) | 0.20 | |
Mental Health | ||||
 Baseline | 45.1 (5.1) | 41.1 (5.0) | – | |
 Change from baseline, wk. 7 | −5.0 (7.2) | − 5.3 (5.0) | 0.05 | |
 Change from baseline, wk. 12 | −5.1 (5.0) | −4.8 (6.5) | −0.05 | |
 Change from baseline, wk. 16 | −5.2 (4.2) | −4.8 (5.0) | −0.11 | |
Orgasm | ||||
 Baseline | 2.9 (1.9) | 3.0 (1.6) | – | |
 Change from baseline, wk. 7 | 0.0 (1.6) | 0.6 (1.6) | −0.37 | |
 Change from baseline, wk. 12 | −0.2 (0.6) | 0.1 (2.0) | −0.16 | |
 Change from baseline, wk. 16 | −0.3 (0.8) | 0.2 (1.9) | −0.35 | |
Pain Intensity | ||||
 Baseline | 45.1 (8.6) | 40.4 (9.0) | – | |
 Change from baseline, wk. 7 | −1.6 (5.8) | 0.6 (7.5) | −0.34 | |
 Change from baseline, wk. 12 | −2.4 (7.0) | 0.6 (6.6) | −0.43 | |
 Change from baseline, wk. 16 | −3.2 (7.3) | 0.8 (8.4) | −0.51 | |
Physical Health | ||||
 Baseline | 39.8 (3.1) | 40.0 (4.4) | – | |
 Change from baseline, wk. 7 | −6.3 (6.2) | −7.2 (6.8) | 0.14 | |
 Change from baseline, wk. 12 | −6.6 (6.0) | −3.5 (5.7) | −0.52 | |
 Change from baseline, wk. 16 | −6.9 (7.3) | −6.9 (6.9) | 0.01 | |
Satisfaction Sex Life | ||||
 Baseline | 49.1 (12.6) | 46.7 (12.8) | – | |
 Change from baseline, wk. 7 | −1.0 (10.4) | 2.4 (6.0) | −0.38 | |
 Change from baseline, wk. 12 | −0.9 (6.6) | 2.9 (12.6) | −0.41 | |
 Change from baseline, wk. 16 | −1.7 (8.2) | −0.3 (11.4) | −0.15 | |
Vaginal Discomfort | ||||
 Baseline | 48.0 (5.9) | 48.0 (4.3) | – | |
 Change from baseline, wk. 7 | 0.7 (4.0) | −1.5 (3.8) | 0.55 | |
 Change from baseline, wk. 12 | 0.5 (4.1) | −1.5 (5.6) | 0.43 | |
 Change from baseline, wk. 16 | −0.8 (3.2) | −2.3 (1.7) | 0.51 | |
Sleep | ||||
 Baseline | 50.1 (6.2) | 48.8 (6.7) | – | |
 Change from baseline, wk. 7 | −2.3 (5.8) | 0.2 (5.2) | −0.44 | |
 Change from baseline, wk. 12 | −2.5 (5.9) | 1.0 (4.7) | −0.61 | |
 Change from baseline, wk. 16 | −3.8 (7.6) | −2.1 (5.0) | −0.26 | |
Quality of Life | ||||
 Baseline (1–5) | 3.1 (0.8) | 2.6 (0.9) | – | |
 Change from baseline, wk. 7 | −0.4 (0.6) | −0.4 (0.8) | 0.10 | |
 Change from baseline, wk. 12 | −0.1 (0.5) | −0.3 (0.9) | 0.34 | |
 Change from baseline, wk. 16 | −0.2 (0.5) | −0.3 (0.9) | 0.09 | |
MPN Symptom Assessment Form Outcomes | Fatigue | |||
 Baseline (0–10) | 5.4 (2.3) | 4.5 (2.8) | – | |
 Change from baseline, wk. 7 | −0.7 (2.5) | −0.8 (3.1) | 0.02 | |
 Change from baseline, wk. 12 | −0.5 (2.2) | −0.6 (2.3) | 0.06 | |
 Change from baseline, wk. 16 | −0.7 (2.4) | 0.6 (2.0) | −0.56 | |
Total Symptom Score | ||||
 Baseline (0–100) | 28.7 (15.6) | 21.9 (13.5) | – | |
 Change from baseline, wk. 7 | −1.4 (9.5) | −5.8 (11.2) | 0.44 | |
 Change from baseline, wk. 12 | −2.7 (8.5) | −4.1 (9.5) | 0.15 | |
 Change from baseline, wk. 16 | 4.4 (8.8) | 7.1 (8.7) | −0.31 |